Therapeutic equivalence study of Verisfield clindamycin + tretinoin gel versus Acnatac and placebo in acne vulgaris

Phase 3, randomised, double-blind trial of clindamycin and tretinoin in acne vulgaris (3 arms), sponsored by Verisfield. Primary endpoints: Percent change in facial inflammatory lesion count and Percent change in facial noninflammatory lesion count. Started Jun 2023; status: completed.